to worsening of their medical condition. Due to the COVID-19 pandemic, the trial was closed for the eight months but is now open to accrual. Conclusions : This trial is currently open and accruing patients. Feasibility will be analyzed after
Search Results
Kedar Kirtane, Jameel Muzaffar, Julie Kish, Laura B Oswald, Brian D Gonzalez, Taylor Welniak, Yvelise Rodriguez, and Christine H Chung
Lilian Hanna, Gordon Taylor Moffat, Wilma Hopman, Pierre-Olivier Gaudreau, and Andrea S. Fung
exploring alternate dosing schedules. The COVID-19 pandemic created a need to cut down on patient visits, thus allowing incorporation of extended dosing (ED) of durvalumab (20mg/kg IV every 4 weeks) into clinical practice. The current study evaluates real
Marwa Abdelsalam, Saeed Shaaban, Ayman Hanafy, and Riham H. AbdelAziz
those living far from their doctor’s office. The mass use of these technologies guaranteed continuity of cancer patients’ care during the COVID-19 pandemic. The objectives of this study are to describe oncologists’ workload in the Arab world and their
Annie L Zhang, Jaime Abraham Perez, and Melinda Hsu
number of patients screened in the two cohorts from TriNetX. This difference is likely due to an increase in the number of HCOs contributing data as time passed and COVID-19 pandemic effects on healthcare utilization. This study found no significant
Adam C. Powell, Logan Horrall, James W. Long, and Amin J. Mirhadi
2021: a period capturing healthcare before the COVID-19 pandemic, the pre-vaccination phase, and the post-vaccination phase. Methods: Claims for lung cancer treatment made between 2019 and 2021 were extracted from the database of a national healthcare
biases in care, and taking on social determinants of health. Of course, all of these conversations are happening in the shadow of the COVID-19 pandemic, which has exposed systemic problems and radically changed care delivery.” The COVID-19 pandemic and
Gene A. Wetzstein, Dima Decker, and James Mond
COVID 19 pandemic; (2) identify the most common respiratory viral pathogens; (3) explore current management approaches and prescriber satisfaction; and (4) explore unmet need and future therapies. Methods: This prospective medical questionnaire was
Jeremie M.P. Lever, Ahmer Irfan, Mona Fouad, Barry Sleckman, J. Bart Rose, Thomas N. Wang, Daniel I. Chu, and Sushanth Reddy
Background: The COVID-19 pandemic has led to the rapid expansion of telehealth use. Telehealth has the potential to improve access for underserved populations who live far distances from well-equipped medical centers. This healthcare modality will
Michelle C Simpson and Danell J Haines
INTRODUCTION : The advent of the COVID-19 pandemic has highlighted the need to expand options for home-based cancer care. For 40 years, millions of patients have selected the home setting to administer infused medications citing improved quality
Margaret Tempero
first COVID-19 vaccination. The fact that, as of writing, 2 vaccines have FDA approval and more are on the way is nothing short of miraculous. The increase in production by the industry giants responsible for these vaccines has also been a tour de force
